(Q38169244)

30 August 2017

title

Toward composite molecular signatures in the phenotyping of asthma (English)

1 reference

30 August 2017

1 reference

Ariane H Wagener

1

1 reference

30 August 2017

Ching Yong Yick

2

1 reference

30 August 2017

Paul Brinkman

3

1 reference

30 August 2017

Marc P van der Schee

4

1 reference

30 August 2017

Niki Fens

5

1 reference

30 August 2017

Peter J Sterk

6

1 reference

30 August 2017

publication date

1 December 2013

1 reference

Proceedings of the American Thoracic Society

30 August 2017

published in

1 reference

30 August 2017

volume

10 Suppl

1 reference

30 August 2017

page(s)

S197-205

1 reference

Emergent phenomena and the secrets of life.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

An integrative systems biology approach to understanding pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

21 January 2018

Bring on the biomarkers

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Personal omics profiling reveals dynamic molecular and medical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Molecular signatures from omics data: from chaos to consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Statistical strategies for avoiding false discoveries in metabolomics and related experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Microarrays, deep sequencing and the true measure of the transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Quality assessment and data handling methods for Affymetrix Gene 1.0 ST arrays with variable RNA integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Batch correction of microarray data substantially improves the identification of genes differentially expressed in rheumatoid arthritis and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Testing significance relative to a fold-change threshold is a TREAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Multidimensionality of microarrays: statistical challenges and (im)possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

How does gene expression clustering work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

A novel method for cross-species gene expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Lebrikizumab treatment in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

RNA-Seq: a revolutionary tool for transcriptomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Applications of next-generation sequencing technologies in functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Glucocorticoid-induced changes in gene expression of airway smooth muscle in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

A new computer method for the storage and manipulation of DNA gel reading data

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Sequencing technologies - the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Small RNA transcriptome investigation based on next-generation sequencing technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Exhaled breath condensate: methodological recommendations and unresolved questions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Asthma severity in childhood and metabolomic profiling of breath condensate

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Electronic nose: current status and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Advances in electronic-nose technologies developed for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Exhaled Breath Profiling Enables Discrimination of Chronic Obstructive Pulmonary Disease and Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Computational methods for transcriptome annotation and quantification using RNA-seq

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

Non-invasive phenotyping using exhaled volatile organic compounds in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201302-035AW

10.1513/ANNALSATS.201302-035AW

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference